Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Sickle Cell DiseasePayerPolicy · BCIDAHO-05-01-048 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Metachromatic Leukodystrophy. Medical Policy MP 5.01.49 Gene Therapies for Metachromatic Leukodystrophy DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-049-89C761038E | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | High Intensity Laser Therapy for Chronic Musculoskeletal Pain Conditions and Bell's Palsy. Medical Policy MP 2.01.108 High Intensity Laser Therapy for Chronic Musculoskeletal Pain ConditionsPayerPolicy · BCIDAHO-02-01-108-91C1EE4667 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Uterus Transplantation for Absolute Uterine Factor Infertility. Medical Policy MP 4.02.06 Uterus Transplantation for Absolute Uterine Factor Infertility DISCLAIMER/INSTRUCTIONS FOR USE ThisPayerPolicy · BCIDAHO-04-02-006-E1C49168A5 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Surgical Left Atrial Appendage Occlusion Devices for Stroke Prevention in Atrial Fibrillation. Medical Policy MP 7.01.172 Surgical Left Atrial Appendage Occlusion Devices for Stroke PreventionPayerPolicy · BCIDAHO-07-01-172-B6BDA06182 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Parenteral, Enteral and Oral Nutrition in the HomePayerPolicy · BCIDAHO-01-02-501 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Metachromatic LeukodystrophyPayerPolicy · BCIDAHO-05-01-051 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Urinary Test for Renal Allograft Rejection. Medical Policy MP 7.03.15 Urinary Test for Renal Allograft Rejection DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidancePayerPolicy · BCIDAHO-07-03-015-AFBFB53F63 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors. Medical Policy MP 7.01.95 Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver TumorsPayerPolicy · BCIDAHO-07-01-095-898C1304CA | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Electrical Stimulation Devices. Medical Policy MP 1.01.507 Electrical Stimulation Devices for Pain Control DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance forPayerPolicy · BCIDAHO-01-01-507-4C32EF7A98 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme DiseasePayerPolicy · BCIDAHO-05-01-008 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Therapeutic Radiopharmaceuticals for Prostate CancerPayerPolicy · BCIDAHO-05-01-043 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Liposuction for Lipedema and Lymphedema. Medical Policy MP 7.01.169 Liposuction for Lipedema and Lymphedema DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance forPayerPolicy · BCIDAHO-07-01-169-CDB2E6CD39 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Suture Button Suspensionplasty Fixation System for Thumb Carpometacarpal OsteoarthritisPayerPolicy · BCIDAHO-07-01-176 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Baroreflex Stimulation Devices. Medical Policy MP 8.01.57 Baroreflex Stimulation Devices DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applying Blue Cross ofPayerPolicy · BCIDAHO-08-01-057-D906EBCE86 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Lumasiran for Primary Hyperoxaluria Type 1PayerPolicy · BCIDAHO-05-01-037 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Givosiran for Acute Hepatic PorphyriaPayerPolicy · BCIDAHO-05-01-040 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Duchenne Muscular DystrophyPayerPolicy · BCIDAHO-05-01-046 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Biological Treatments for Refractory Myasthenia Gravis. Medical Policy MP 5.01.539 Biological Treatments for Refractory Myasthenia Gravis DISCLAIMER/INSTRUCTIONS FOR USE This medical policyPayerPolicy · BCIDAHO-05-01-539-118DF1E48F | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Cerebral AdrenoleukodystrophyPayerPolicy · BCIDAHO-05-01-545 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Intravenous Ustekinumab for Inflammatory Bowel DiseasePayerPolicy · BCIDAHO-05-01-664 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Intravenous InfliximabPayerPolicy · BCIDAHO-05-01-668 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Subcutaneous Continuous Infusion Pharmacologic Treatment of Parkinson’s DiseasePayerPolicy · BCIDAHO-05-01-669 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Orencia (abatacept) for Intravenous UsePayerPolicy · BCIDAHO-05-01-671 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Low-Dose Radiotherapy for Non-Oncologic IndicationsPayerPolicy · BCIDAHO-07-01-179 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Percutaneous Revascularization Procedures for Lower Extremity Peripheral Arterial DiseasePayerPolicy · BCIDAHO-07-01-178 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Axillary Reverse Mapping for Prevention of Breast Cancer-Related LymphedemaPayerPolicy · BCIDAHO-07-01-173 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Intracellular Micronutrient AnalysisPayerPolicy · BCIDAHO-02-04-073 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Treatment of Hereditary Transthyretin-Mediated Amyloidosis in Adult PatientsPayerPolicy · BCIDAHO-05-01-530 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Remote Electrical Neuromodulation for Migraines. Medical Policy MP 7.01.171 Remote Electrical Neuromodulation for Migraines DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-07-01-171-B63D9A4342 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | General Coverage GuidelinesPayerPolicy · BCIDAHO-09-01-501 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Continuous Glucose MonitoringPayerPolicy · BCIDAHO-01-01-020 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Renal Denervation for Uncontrolled Hypertension. Medical Policy MP 7.01.136 Renal Denervation for Uncontrolled Hypertension DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-07-01-136-0E16ECE116 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Simponi Aria (Golimumab) for Intravenous Use. Medical Policy MP 5.01.670 Simponi Aria (golimumab) for Intravenous Use DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides generalPayerPolicy · BCIDAHO-05-01-670-67638B3210 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gazyva (obinutuzumab) for Non-oncologic UsesPayerPolicy · BCIDAHO-05-01-673 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Gene Therapies for Treatment of Wounds in Dystrophic Epidermolysis BullosaPayerPolicy · BCIDAHO-05-01-047 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Botulinum ToxinPayerPolicy · BCIDAHO-05-01-505 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Krystexxa. Medical Policy 5.01.665 Krystexxa DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applying Blue Cross of Idaho benefit plans (for purposes of thisPayerPolicy · BCIDAHO-05-01-665-43DEAED803 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Amniotic Membrane and Amniotic Fluid. Medical Policy MP 7.01.149 Amniotic Membrane and Amniotic Fluid DISCLAIMER/INSTRUCTIONS FOR USE This medical policy provides general guidance for applyingPayerPolicy · BCIDAHO-07-01-149-E6B9FAD9E0 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | High-Dose Rate Temporary Prostate BrachytherapyPayerPolicy · BCIDAHO-08-01-033 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Digital Health Technologies: Therapeutic ApplicationsPayerPolicy · BCIDAHO-03-03-002 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Rituximab For Nononcologic UsesPayerPolicy · BCIDAHO-05-01-672 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Automated Insulin Delivery SystemsPayerPolicy · BCIDAHO-01-01-530 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Prostate Artery Embolization for Benign Prostatic HyperplasiaPayerPolicy · BCIDAHO-07-01-055 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Intracoronary Drug Delivery Balloon ProceduresPayerPolicy · BCIDAHO-07-01-097 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Transurethral Water Vapor Thermal Therapy and Transurethral Water Jet Ablation for Benign Prostatic Hyperplasia. Medical Policy MP 2.01.549 Transurethral Water Vapor Thermal Therapy andPayerPolicy · BCIDAHO-02-01-549-F08A928B61 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Treatment of Nasal Valve Collapse and Nasal Septal Swell Bodies. Medical Policy MP 7.01.663 Treatment of Nasal Valve Collapse and Nasal Septal Swell Bodies DISCLAIMER/INSTRUCTIONS FOR USE ThisPayerPolicy · BCIDAHO-07-01-663-559784E9CC | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Robotic-Assisted SurgeryPayerPolicy · BCIDAHO-10-01-610 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Ryoncil (remestemcel-L)PayerPolicy · BCIDAHO-05-01-674 | New policy |
|---|
| Aug 2, 2026 | Blue Cross of Idaho | Treatment of Tarlov CystPayerPolicy · BCIDAHO-07-01-076 | New policy |
|---|